Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system agents. Its structure, featuring a bromo-substituted dihydroisoquinoline and a trifluoroacetyl group, supports the creation of potent receptor modulators, making it valuable in medicinal chemistry for designing drugs targeting neurological disorders. The trifluoroacetyl moiety enhances solubility and metabolic stability, aiding in brain penetration. Also employed in the preparation of kinase inhibitors and other therapeutic agents due to its ability to improve binding affinity.